These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
56 related articles for article (PubMed ID: 25137846)
1. [Effect of Chinese drugs for Pi strengthening Shen benefiting on the immunity function of HIV patients' specific T cells]. Li WH; Li CY; Yan HP; Zhang X; Zhao DT; Li XH Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Jul; 34(7):812-5. PubMed ID: 25137846 [TBL] [Abstract][Full Text] [Related]
2. [Effect of Qiling Decoction combined HAART on expression levels of Treg cells and Th17 in HIV/AIDS patients]. Xu WF; Wu Y; Pan GS; Zhong JP; Lan SB; Chen XF; Lu QQ Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Feb; 34(2):157-61. PubMed ID: 24672938 [TBL] [Abstract][Full Text] [Related]
3. [Effects of traditional Chinese medicine on CD4 + T cell counts and HIV viral loads during structured treatment interruption in highly active antiretroviral therapy]. Zhao HX; Zhang FJ; Han N; Lan MD; Yao J; Liu ZY; Lu LH; Wei HS Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Oct; 28(5):658-61. PubMed ID: 17121226 [TBL] [Abstract][Full Text] [Related]
4. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression. Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945 [TBL] [Abstract][Full Text] [Related]
5. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study. Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166 [TBL] [Abstract][Full Text] [Related]
6. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients. Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940 [TBL] [Abstract][Full Text] [Related]
7. Low-dose daily subcutaneous interleukin-2 in combination with highly active antiretroviral therapy in HIV+ patients: a randomized controlled trial. Lalezari JP; Beal JA; Ruane PJ; Cohen CJ; Jacobson EL; Sundin D; Leong WP; Raffanti SP; Wheeler DA; Anderson RD; Keiser P; Schrader SR; Goodgame JC; Steinhart CR; Murphy RL; Wolin MJ; Smith KA HIV Clin Trials; 2000; 1(3):1-15. PubMed ID: 11590500 [TBL] [Abstract][Full Text] [Related]
8. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients. Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174 [TBL] [Abstract][Full Text] [Related]
9. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy. Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203 [TBL] [Abstract][Full Text] [Related]
10. A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. Hecht FM; Wang L; Collier A; Little S; Markowitz M; Margolick J; Kilby JM; Daar E; Conway B; Holte S; J Infect Dis; 2006 Sep; 194(6):725-33. PubMed ID: 16941337 [TBL] [Abstract][Full Text] [Related]
11. Comparison of prognostic importance of latest CD4+ cell count and HIV RNA levels in patients with advanced HIV infection on highly active antiretroviral therapy. MacArthur RD; Perez G; Walmsley S; Baxter JD; Mullin CM; Neaton JD; ; HIV Clin Trials; 2005; 6(3):127-35. PubMed ID: 16192247 [TBL] [Abstract][Full Text] [Related]
12. Thymic Function during 12 Months of Highly Active Antiretroviral Therapy in Thai HIV-Infected Patients with Normal and Slow Immune Recovery. Kingkeow D; Srithep S; Praparattanapan J; Supparatpinyo K; Pornprasert S Jpn J Infect Dis; 2015; 68(5):353-6. PubMed ID: 25720642 [TBL] [Abstract][Full Text] [Related]
13. [Clinical study on treatment of HIV infected persons based on viral load detection and CD4+ T lymphocyte counting]. Lin X; Xu L; Feng Y; Li J; Pei L; Shen T; Shao Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Sep; 16(3):211-4. PubMed ID: 12665921 [TBL] [Abstract][Full Text] [Related]
14. Kaposi's sarcoma-associated herpesvirus-specific immune reconstitution and antiviral effect of combined HAART/chemotherapy in HIV clade C-infected individuals with Kaposi's sarcoma. Bihl F; Mosam A; Henry LN; Chisholm JV; Dollard S; Gumbi P; Cassol E; Page T; Mueller N; Kiepiela P; Martin JN; Coovadia HM; Scadden DT; Brander C AIDS; 2007 Jun; 21(10):1245-52. PubMed ID: 17545700 [TBL] [Abstract][Full Text] [Related]
15. Factors influencing increases in CD4 cell counts of HIV-positive persons receiving long-term highly active antiretroviral therapy. Smith CJ; Sabin CA; Youle MS; Kinloch-de Loes S; Lampe FC; Madge S; Cropley I; Johnson MA; Phillips AN J Infect Dis; 2004 Nov; 190(10):1860-8. PubMed ID: 15499544 [TBL] [Abstract][Full Text] [Related]
16. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy. Stone SF; Price P; French MA HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533 [TBL] [Abstract][Full Text] [Related]
17. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy. Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR; Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328 [TBL] [Abstract][Full Text] [Related]
18. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M; Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216 [TBL] [Abstract][Full Text] [Related]